Target intelligence / Profile preview

Spalt-like transcription factor 2 (SALL2)

Target
SALL2
Molecular classification
Transcription factor, Zinc finger protein
01

Overview

Spalt-like transcription factor 2 (SALL2) is a **zinc finger transcription factor** in the Spalt-like family, conserved from nematodes to humans. It contains an N-terminal C2HC zinc finger domain, a glutamine-rich region, and several C2H2 zinc finger domains[1]. SALL2 controls key biological processes including neuronal differentiation, embryonic development, and regulation of cell migration through control of focal adhesion turnover and integrin β1 expression[1]. It exists as two main isoforms with tissue-specific functions. In development, SALL2 is expressed in the kidney, brain, and other tissues, but knockout studies in mice suggest it is not essential for embryonic or kidney development[2]. In cancer biology, SALL2 is regarded as a tumor suppressor in certain tissues, regulating the cell cycle and apoptosis, but acts as an oncogene in others. Its relevance for disease arises from its role in migration, cell cycle regulation, and differentiation; however, SALL2 is not currently a direct therapeutic target and no approved drugs are known to target this protein[1][2].

Other names
Sal-like protein 2KIAA0360SAL2ZNF795Sal-2hSal2COLBHSAL2p150(Sal2)zinc finger protein 795zinc finger protein Spalt-2
02

Biological functions

Neuronal differentiationCell migrationCell adhesion and focal adhesion dynamicsRegulation of integrin β1 expressionCell cycle regulationInduction of apoptosis under genotoxic stressEmbryonic development
03

Disease associations

Cancer (tumor suppressor and possible oncogene roles depending on tissue context)Congenital abnormalities (via regulation of cell migration)
04

Safety considerations

Current data does not identify direct safety concerns related to SALL2 as a therapeutic target, as it is presently not targeted by approved drugs or therapies.Its dual role in cancer (tumor suppressor in some contexts, potential oncogene in others) could complicate therapeutic targeting[1].

Beyond the preview

Go deeper on Spalt-like transcription factor 2 (SALL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spalt-like transcription factor 2 (SALL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call